Abstract:Objective To study the therapeutic effect of combined antihuman IgG antibody with mitomycin(MMC) on human bladder cancer ceils and the primary mechanism. Methods In vitro an-tiproliferation effects of goat antihuman IgG antibody(Ab) with MMC, alone or together, on human bladder cancer cell line T24 were tested by MTT assay. Flow cytometer(FCM) was used to detect T24 cell apoptosis. Detections of activated caspase-3 and PARP[poly(ADP-ribose) polymerase] were carried out by Western blot analysis. In vivo antitumor effects of Ab of anti-human IgG with MMC were assessed using T24 xenograft in BALB/c nude mice model. Results The inhibitory rates of tumor growth of Ab, M MC and Ab+ MMC on T24 cell were (25.02±6.71)%, (32.31±6.46)% and (73.66±5.81)%, respectively. The rates of apoptotic cell of PBS, normal goat IgG, Ab, MMC, MMC±normal goat IgG, and MMC+Ab were 1.7%, 2.3%, 20.7%, 22.4%, 28.3% and 53.8%, respectively. Western blot shows Caspase-3 and PARP were cleaved in T24 cell during the course of apoptosis induced by Ab and MMC, and indicated that cell apoptosis was associated with caspase-3 and PARP activation. Under the treatment of normal goat IgG, Ab, MMC, and MMC+Ab, the in-hibitory rates of T24 xenografts in BALB/c nude mice were 2.31%, 12.73%, 36. 81%, and 50.51%, respectively. Histological examination demonstrated significant necrosis and apoptosis in the mice treated with alone MMC or Ab but no control goat IgG or PBS, in addition, HE displayed more extensive necrosis and apoptosis in the mice with MMC+Ab.Conclusion Antihuman IgG Ab with MMC has in vitro and in vivo inhibitory effects of human bladder cancer T24 , which are related to in-ducing cell apoptosis.

Preparation and the cytotoxicity of conjugate composed of pingyangmycin and monoclonal antibody against human lung cancer

[Effect of Antibody-Targeted Chemotherapy with Pingyangmycin on Prostate Cancer Cells in Vitro].

Target Therapy Combined ~(188)re with Pingyangmycin on Prostate Cancer Cells in Vitro

Preparation of Antigastric Cancer Monoclonal Antibody-Mitomycin-C Conjugate Via A New Type of Conjugation Method

[Preparation of Monoclonal Antibody Against Lung Cancer and Identification of Its Targeting Antigen].

Experimental Study on the Therapeutic Effect of Combined Antihuman IgG Antibody with Mitomycin C on Human Bladder Cancer Cells

Preparation of Lymphatic Targeting Dosage Form:Pingyangmycin Absorbed on Activated Carbon Nanoparticles

Targeted Anti-Tumor Agents and Their Cytotoxicity on Gastric Cancer Cells in Vitro.

Effect of Targeting Treatment of Mitomycin-C Immunoconjugate on Stomach Neoplasm

Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery

Experiment on Lymphatic Chemotherapy of Oral Squamous Carcinoma Using Lymphatic Targeting Dosage Form: Pingyanginycin Absorbed on Activated Carbon Nanoparticles

Antitumor activity of pingyangmycin against colorectal cancer

A Novel Monoclonal Antibody Induces Cancer Cell Apoptosis and Enhances the Activity of Chemotherapeutic Drugs

THE SPECIFIC PHOTODYNAMIC EFFECTS OF MONOCLONAL ANTIBODIES CONJUGATED WITH HEMATOPORPHYRIN DERIVATIVE ON GASTRIC CANCER IN VITRO AND IN VIVO

Effect of anti-CD3-EGFR bispecific antibody-labeled DCCIK immune cells on proliferation of lung cancer cells

Preparation and In-Vitro Bioactivity of a Novel Superantigen Conjugate Targeting Bladder Carcinoma

Preparation of Egfr Monoclonal Antibody Conjugated Nanoparticles and Targeting to Hepatocellular Carcinoma

Synthesis of a novel CS-g-MMCs conjugate and the inhabitation on the proliferation of Tenon's capsule fibroblasts in vitro.

A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma.

Preparation and stimulatory bioactivity evaluation of conjugate of superantigen and the Fab frag ment of McAb against human bladder carcinoma